Literature DB >> 16622845

Matrix metalloproteinases in development and disease.

Vincent Lemaître1, Jeanine D'Armiento.   

Abstract

Matrix metalloproteinases (MMPs) are key modulators of many biological processes during pathophysiological events, such as skeletal formation, angiogenesis, cellular migration, inflammation, wound healing, coagulation, lung and cardiovascular diseases, arthritis, and cancer. Twenty-four members of the MMP family have been identified in humans, degrading many components of the extracellular matrix, cellular receptors, and cytokines. This review describes the molecular structure, activation and inhibition, and substrate specificity of MMPs, and their biological function in development and disease. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622845     DOI: 10.1002/bdrc.20065

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  62 in total

1.  The influence of a biologically relevant substratum topography on human aortic and umbilical vein endothelial cells.

Authors:  Clayton T McKee; Joshua A Wood; Irene Ly; Paul Russell; Christopher J Murphy
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Transcriptome-Wide Regulation of Key Developmental Pathways in the Mouse Neural Tube by Prenatal Alcohol Exposure.

Authors:  Karen E Boschen; Travis S Ptacek; Jeremy M Simon; Scott E Parnell
Journal:  Alcohol Clin Exp Res       Date:  2020-07-01       Impact factor: 3.455

3.  Antagonistic enzymes may generate alternate phase transitions leading to ephemeral gels.

Authors:  Sébastien Giraudier; Véronique Larreta-Garde
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

Review 4.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

5.  Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1.

Authors:  Hao H Ho; Taras T Antoniv; Jong-Dae Ji; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Protective action of doxycycline against diabetic cardiomyopathy in rats.

Authors:  N Yaras; M Sariahmetoglu; A Bilginoglu; A Aydemir-Koksoy; A Onay-Besikci; B Turan; R Schulz
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

7.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

8.  Minocycline attenuates cardiac dysfunction in tumor-burdened mice.

Authors:  Raymond D Devine; Clayton M Eichenseer; Loren E Wold
Journal:  J Mol Cell Cardiol       Date:  2016-09-20       Impact factor: 5.000

9.  The presence of extracellular matrix degrading metalloproteinases during fetal development of the intervertebral disc.

Authors:  J P H J Rutges; P G J Nikkels; F C Oner; K D Ottink; A J Verbout; R J M Castelein; L B Creemers; W J A Dhert
Journal:  Eur Spine J       Date:  2010-04-10       Impact factor: 3.134

10.  Tumor growth and angiogenesis is impaired in CIB1 knockout mice.

Authors:  Mohamed A Zayed; Weiping Yuan; Dan Chalothorn; James E Faber; Leslie V Parise
Journal:  J Angiogenes Res       Date:  2010-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.